0

Journal Articles

in Drug/Vaccine Safety
 61-80 of 90 Articles
Commentary |  May 02, 2007
FDA Responds to Institute of Medicine Drug Safety Recommendations—In Part
Bruce M. Psaty, MD, PhD; R. Alta Charo, JD
JAMA. 2007;297(17):1917-1920. doi:10.1001/jama.297.17.1917.
Medical News and Perspectives |  February 14, 2007
FDA Panel Seeks to Balance Risks in Warnings for Antidepressants
JAMA. 2007;297(6):573-580. doi:10.1001/jama.297.6.573.
Commentary |  January 10, 2007
A New Era of Unapproved Drugs:  The Case of Abigail Alliance v Von Eschenbach
Peter D. Jacobson, JD, MPH; Wendy E. Parmet, JD
JAMA. 2007;297(2):205-208. doi:10.1001/jama.297.2.205.
Medical News and Perspectives |  November 01, 2006
IOM: Overhaul Drug Safety Monitoring
JAMA. 2006;296(17):2075-2078. doi:10.1001/jama.296.17.2075.
Health Agencies Update |  July 26, 2006
Medication Errors
JAMA. 2006;296(4):384. doi:10.1001/jama.296.4.384-a.
Commentary |  May 03, 2006
How the US Drug Safety System Should Be Changed
Brian L. Strom, MD, MPH
JAMA. 2006;295(17):2072-2075. doi:10.1001/jama.295.17.2072.
Health Agencies Update |  January 25, 2006
Black Box Warnings
JAMA. 2006;295(4):377. doi:10.1001/jama.295.4.377-c.
Editorial |  December 07, 2005
Vaccine Safety—Achieving the Proper Balance
Kathleen M. Neuzil, MD, MPH; Marie R. Griffin, MD, MPH
JAMA. 2005;294(21):2763-2765. doi:10.1001/jama.294.21.2763.
Capitol Health Call |  April 13, 2005
Clinical Trial Registry
JAMA. 2005;293(14):1718. doi:10.1001/jama.293.14.1718-c.
Medical News and Perspectives |  April 06, 2005
FDA Panel: Keep COX-2 Drugs on Market
JAMA. 2005;293(13):1571-1583. doi:10.1001/jama.293.13.1571.
Health Agencies Update |  March 23, 2005
Drug Safety Monitoring
JAMA. 2005;293(12):1440. doi:10.1001/jama.293.12.1440-d.
Original Contribution |  March 09, 2005 FREE
Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors
Ross Koppel, PhD; Joshua P. Metlay, MD, PhD; Abigail Cohen, PhD; et al.
JAMA. 2005;293(10):1197-1203. doi:10.1001/jama.293.10.1197.
Commentary |  June 16, 2004
Using Pharmacogenetics to Improve Drug Safety and Efficacy
Susanne B. Haga, PhD; Wylie Burke, MD, PhD
JAMA. 2004;291(23):2869-2871. doi:10.1001/jama.291.23.2869.
Medical News and Perspectives |  April 28, 2004
Similar Drug Names a Risky Prescription
JAMA. 2004;291(16):1948-1949. doi:10.1001/jama.291.16.1948.
Medical News and Perspectives |  April 14, 2004
Bar Codes Mandated for Hospital Meds
JAMA. 2004;291(14):1685-1686. doi:10.1001/jama.291.14.1685.
Original Contribution |  September 17, 2003 FREE
Retrospective Drug Utilization Review, Prescribing Errors, and Clinical Outcomes
Sean Hennessy, PharmD, PhD; Warren B. Bilker, PhD; Lan Zhou, PhD; et al.
JAMA. 2003;290(11):1494-1499. doi:10.1001/jama.290.11.1494.
Editorial |  March 05, 2003
Medication Safety:  Moving From Illusion to Reality
David Classen, MD, MS
JAMA. 2003;289(9):1154-1156. doi:10.1001/jama.289.9.1154.
From the Food and Drug Administration |  October 02, 2002
Device for Young Diabetics
JAMA. 2002;288(13):1579. doi:10.1001/jama.288.13.1579.
Clinical Crossroads Update |  June 26, 2002
A 40-Year-Old Woman Who Noticed a Medication Error, 1 Year Later
Anne-Marie J. Audet, MD, MSc; Erin E. Hartman, MS
JAMA. 2002;287(24):3258. doi:10.1001/jama.287.24.3258.
Original Contribution |  May 01, 2002 FREE
Timing of New Black Box Warnings and Withdrawals for Prescription Medications
Karen E. Lasser, MD, MPH; Paul D. Allen, MD, MPH; Steffie J. Woolhandler, MD, MPH; et al.
JAMA. 2002;287(17):2215-2220. doi:10.1001/jama.287.17.2215.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Dermatology
Practice Gaps  |  April 01, 2013
Propranolol to Treat Hemangiomas of Infancy:  Safety and Side Effect Recognition
Comment on “Retrospective Review of Adverse Effects from Propranolol in Infants”
Jonathan A. Dyer, MD
JAMA Dermatology
Research Letters  |  April 01, 2013
Retrospective Review of Adverse Effects From Propranolol in Infants
Eun-Kyung M. Kwon, BA; Shawna Joachim, BA; Dawn H. Siegel, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems